FreeGuest Editorial First exhibit at Museum of Medicine and Biomedical Discovery to focus on the history of cancer researchFrom despair to discovery to triumph May 16, 2025Vol.51 No.19By Mace L. Rothenberg
FreeIn the Archives Ashtrays in ivory towers: Two centuries of tobacco’s ties to academia May 16, 2025Vol.51 No.19
FreeTrials & Tribulations Working with cancer: Rethinking long-term health for working-age adult cancer survivors May 09, 2025Vol.51 No.18By Susan A. Speckhart, Rebecca Miksad and Lidia Schapira
FreeIn the Archives Walter Lawrence Jr.: “The National Cancer Act really gave us a lot of enthusiasm about the future.” May 09, 2025Vol.51 No.18By Katie Goldberg
Free Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child May 02, 2025Vol.51 No.17By Jacquelyn Cobb
FreeObituary Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97An architect of today’s Roswell Park April 11, 2025Vol.51 No.14By Roswell Park Comprehensive Cancer Center
FreeObituary Tomasi revived basic and clinical research at Roswell Park April 11, 2025Vol.51 No.14By Jerome Yates
FreeIn the Archives Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings April 11, 2025Vol.51 No.14
FreeIn the Archives In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously April 04, 2025Vol.51 No.13By Jacquelyn Cobb
FreeIn the Archives Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted March 28, 2025Vol.51 No.12